姚晶,邵兴慧

• 1:首都医科大学附属北京安贞医院心内科
• 2:国家心血管病中心北京协和医学院中国医学科学院阜外医院心内科

摘要(Abstract)：

经导管电外科治疗是近年来发展起来的一种新型结构性心脏病介入技术。该技术利用射频能量通过导管系统对心血管组织进行穿刺、切割或消融，为一些复杂的结构性心脏病患者提供了新的治疗选择。该技术从最初的简单瓣膜穿刺发展到现在的复杂瓣膜改形，开发出多种创新术式用于解决介入治疗中的关键临床问题。其基本原理是利用射频能量加热和气化目标组织，同时最大限度地减少对周围组织的损伤。本文综述了经导管电外科治疗的基本原理、技术特点、临床应用以及未来发展前景。目前的应用包括闭塞性病变的再通、心腔间穿刺和组织切割等。尽管在多种复杂病例中显示出良好疗效，该技术仍面临着学习曲线陡峭、需要专用设备等挑战。随着领域的不断发展，经导管电外科治疗有望在结构性心脏病介入治疗中发挥越来越重要的作用，但仍需要更多的长期随访数据来全面评估其安全性和有效性。

关键词(KeyWords)： 经导管电外科治疗;结构性心脏病;射频能量;导管介入;微创手术

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 姚晶,邵兴慧

参考文献(References)：

• [1]中国医师协会心血管分会结构性心脏病学组,周达新,吴永健.结构性心脏病介入治疗2023年度报告精要[J].中国介入心脏病学杂志,2024,32(3):121-135.DOI:10.3969/j.issn.1004-8812.2024.03.001.
• [2]Rosenthal E,Qureshi SA,Chan KC,et al.Radiofrequencyassisted balloon dilatation in patients with pulmonary valve atresia and an intact ventricular septum[J].Br Heart J,1993,69(4):347-351.DOI:10.1136/hrt.69.4.347.
• [3]Khan JM,Rogers T,Greenbaum AB,et al.Transcatheter electro surgery:JACC state-of-the-art review[J].J Am Coll Cardiol,2020,75(12):1455-1470.DOI:10.1016/j.jacc.2020.01.035.
• [4]Greenbaum AB,O'Neill WW,Paone G,et al.Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients:initial human experience[J].J Am Coll Cardiol,2014,63(25 Pt A):2795-2804.DOI:10.1016/j.jacc.2014.04.015.
• [5]王墨扬,周政,牛冠男,等.经导管主动脉瓣置换术2023年度进展[J].中国介入心脏病学杂志,2024,32(1):14-19.DOI:10.3969/j.issn.1004-8812.2024.01.004.
• [6] Babaliaros VC,Greenbaum AB,Khan JM,et al.Intentional percutaneous laceration of the anterior mitral leaflet to prevent oufflow obstruction during transcatheter mitral valve replacement:first-in-human experience[J]JACC Cardiovasc Interv,2017,10(8):798-809.DOI:10.1016/j.jcin.2017.01.035.
• [7] Khan JM,Dvir D,Greenbaum AB,et al.Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement:concept to first-in-human[J]JACC Cardiovasc Interv,2018,11(7):677-689.DOI:10.1016/j.j cin.2018.01.247.
• [8]Bruce CG,Khan JM,Rogers T,et al.Transcatheter electro surgery:a narrative review[J].Circ Cardiovasc Interv,2023,16(3):e012019.DOI:10.1161/CIRCINTERVENTIONS.122.012019.
• [9]Veldtman GR,Hartley A,Visram N,et al.Radiofrequency applications in congenital heart disease[J].Expert Rev Cardiovasc Ther,2004,2(1):117-126.DOI:10.1586/14779072.2.1.117.
• [10]Baim DS,Braden G,Heuser R,et al.Utility of the safecross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions(results from the guided radio frequency energy ablation of total occlusions registry study)[J].Am J Cardiol,2004,94(7):853-858.DOI:10.1016/j.amjcard.2004.06.017.
• [11]Keller EJ,Gupta SA,Bondarev S,et al.Single-center retrospective review of radiofrequency wire recanalization of refractory central venous occlusions[J].J Vasc Interv Radiol,2018,29(11):1571-1577.DOI:10.1016/j.jvir.2018.06.017.
• [12]Hsu JC,Badhwar N,Gerstenfeld EP,et al.Randomized trial of conventional transseptal needle versus radiofrequency energyneedle puncture for left atrial access(the TRAVERSE-LA study)[J].J Am Heart Assoc,2013,2(5):e000428.DOI:10.1161/JAHA.113.000428.
• [13]Greenbaum AB,Babaliaros VC,Chen MY,et al.Transcaval access and closure for transcatheter aortic valve replacement:a prospective investigation[J].J Am Coll Cardiol,2017,69(5):511-521.DOI:10.1016/j.jacc.2016.10.024.
• [14]Lederman RJ,Babaliaros VC,Lisko JC,et al.Transcaval versus transaxillary TAVR in contemporary practice:a propensity-weighted analysis[J].JACC Cardiovasc Interv,2022,15(9):965-975.DOI:10.1016/j.jcin.2022.03.014.
• [15]Gamble JHP,Herring N,Ginks MR,et al.Endocardial left ventricular pacing across the interventricular septum for cardiac resynchronization therapy:clinical results of a pilot study[J].Heart Rhythm,2018,15(7):1017-1022.DOI:10.1016/j.hrthm,2018.02.032.
• [16]尚小珂,虞奇峰,杨洁琰,等.经导管二尖瓣置换技术难点概述[J].中国介入心脏病学杂志,2023,31(8):609-614.DOI:10.3969/j.issn.1004-8812.2023.08.008.
• [17]Khan JM,Babaliaros VC,Greenbaum AB,et al.Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement[J].J Am Coll Cardiol,2019,73(20):2521-2534.DOI:10.1016/j.jacc.2019.02.076.
• [18]Khan JM,Babaliaros VC,Greenbaum AB,et al.Preventing coronary obstruction during transcatheter aortic valve replacement:results from the multicenter international BASILICA registry[J]JACC Cardiovasc Interv,2021,14(9):941-948.DOI:10.1016/j.jcin.2021.02.035.
• [19] Khan JM,Lederman RJ,Sanon S,et al.Transcatheter mitral valve replacement after transcatheter electro surgical laceration of Alfieri stitch(ELASTIC):first-in-human report[J].JACC Cardiovasc Interv,2018,11(8):808-811.DOI:10.1016/j.jcin,2017.11.035.
• [20]Lisko JC,Greenbaum AB,Guyton RA,et al.Electro surgical detachment of MitraClips from the anterior mitral leaflet prior to transcatheter mitral valve implantation[J].JACC Cardiovasc Interv,2020,13(20):2361-2370.DOI:10.1016/j.jcin.2020.06.047.
• [21]Inci EK,Greenbaum AB,Lederman RJ,et al.Transcatheter electro surgical laceration and stabilization of failed MitraClip[s]/SAPIEN M3 for treatment of failed MitraClip[J].Circ Cardiovasc Interv,2022,15(5):e012014.DOI:10.1161/CIRCINTERVENTIONS.122.012014.
• [22]Babaliaros VC,Gleason PT,Xie JX,et al.Toward transcatheter leaflet removal with the cathedral procedure:catheter electro surgical debulking and removal[J].JACC Cardiovasc Interv,2022,15(16):1678-1680.DOI:10.1016/j.jcin.2022.05.038.
• [23]Greenbaum AB,Khan JM,Bruce CG,et al.Transcatheter myotomy to treat hypertrophic cardiomyopathy and enable transcatheter mitral valve replacement:first-in-human report of septal scoring along the midline endocardium[J].Circ Cardiovasc Interv,2022,15(6):e012106.DOI:10.1161/CIRCINTERVENTIONS.122.012106.
• [24] Khan JM,Greenbaum AB,Babaliaros VC,et al.The BASILICA trial:prospective multicenter inve stigation of intentional leaflet laceration to prevent TAVR coronary obstruction[J].JACC Cardiovasc Interv,2019,12(13):1240-1252.DOI:10.1016/j.jcin.2019.03.035.